This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institutes of Health (NIH), part of the Department of Health and Human Services (HHS), to Luna Innovations Incorporated. The objective of this $299,956 Firm Fixed Price contract is to develop a novel layer-by-layer (LBL) RNA vaccine that can provide long-lasting protection against HIV. Luna Innovations is a small business that specializes in fiber optic sensing and measurement systems, and has previously...
This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the National Institutes of Health (NIH), to Luna Labs USA LLC, a subsidiary of Luna Innovations Incorporated, for the development of a platform for the delivery of mRNA-based HIV vaccines. The $1,999,997.00 Firm-Fixed-Price contract involves collaborating with New York University (NYU) to evaluate the immunogenicity of novel HIV...
The U.S. Defense Health Agency (DHA) awarded a Small Business Innovation Research (SBIR) Phase I contract to Luna Labs USA LLC, a small business based in Charlottesville, Virginia. The contract, valued at $249,996.84, is for a project titled "Layer-by-Layer Sustained Delivery for HIV-1 Vaccine" under the DHA's SBIR program. The contract is a Firm Fixed Price Purchase Order with a completion date of August 26, 2025. Luna Labs USA LLC is a division of Luna Innovations Incorporated and...
This contract was awarded by the Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID) to Luna Labs USA LLC, a division of Luna Innovations Incorporated. The $599,993.00 award falls under the Small Business Innovation Research (SBIR) program and is for the development of "Reagents for Immunologic Analysis of Non-mammalian and Underrepresented Mammalian Models." Luna Labs USA LLC is a small...
This is a $299,999.00 Firm Fixed Price Definitive Contract awarded by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to Luna Innovations Incorporated, a small business manufacturer, for the CNT-VECTORED DELIVERY OF MRNA FOR HIV-VACCINES research project under the Small Business Innovation Research (SBIR) Program Phase I. The contract is for the development and delivery of products and services related to this...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a Small Business Innovation Research (SBIR) Phase II contract to Luna Innovations Incorporated, a manufacturer of goods, for the development of "Innovative Oral Formulations for Anti-TB Drugs". The firm-fixed-price contract, with a potential value of $1,499,796.00, was awarded on August 28, 2018, and is set to be completed by November 30, 2020. As a...
The National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the U.S. Department of Health and Human Services, has awarded a $299,968 Small Business Innovation Research (SBIR) Phase I contract to Vitruvian Bio, LLC, a small disadvantaged and woman-owned business. The contract is for the development of an "Electrochemical Self-Monitoring Device for Rapid Nucleic Acid Based Testing of HIV-1". This specialized medical research and diagnostic technology...
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a Firm Fixed Price Definitive Contract to Ai Biosciences, Inc., a minority-owned, self-certified small disadvantaged business, for the development of a low-cost, automated, and rapid home HIV viral load test. The award, which is part of the Small Business Innovation Research (SBIR) Program Phase I, has a potential value of $294,538.00 and a completion date of...
This is a $224,953.00 Firm Fixed Price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Luna Innovations Incorporated, a small business manufacturer, under the SBIR program. The contract is for the development and delivery of a "Magnetic Microparticle Kit for Cell Removal from Blood" and has a period of performance ending on August 17, 2016. This contract is for Phase I research and development under the SBIR program, which supports small...
The U.S. National Institute of Allergy and Infectious Diseases (NIAID) awarded a $306,206.00 firm fixed-price Small Business Innovation Research (SBIR) Phase I contract to Intuitive Biosciences Inc., a small disadvantaged business, to develop "THE EV-HIV ASSAY, A POINT-OF-CARE LATERAL FLOW IMMUNOASSAY TO ACCURATELY IDENTIFY HIV INFECTION FROM BLOOD-BASED EXTRACELLULAR VESICLES." This contract is linked to a broader SBIR solicitation issued by the NIAID and Centers for Disease Control...